Glamych

ZYNE

NASDAQ:ZYNE   None
Zynerba Pharma Receives FDA Guidance For Phase 3 Trial Of Zygel

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.